Stephen J. Garry & Associates LLC Purchases 4,430 Shares of SPDR S&P Biotech ETF $XBI

Stephen J. Garry & Associates LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 191.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,745 shares of the exchange traded fund’s stock after purchasing an additional 4,430 shares during the quarter. SPDR S&P Biotech ETF accounts for 0.7% of Stephen J. Garry & Associates LLC’s investment portfolio, making the stock its 26th largest holding. Stephen J. Garry & Associates LLC’s holdings in SPDR S&P Biotech ETF were worth $862,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. WESPAC Advisors SoCal LLC increased its stake in SPDR S&P Biotech ETF by 174.9% during the 1st quarter. WESPAC Advisors SoCal LLC now owns 13,858 shares of the exchange traded fund’s stock valued at $1,770,000 after purchasing an additional 8,816 shares in the last quarter. Aspen Investment Management Inc bought a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $316,000. Cornerstone Planning LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $224,000. Rockefeller Capital Management L.P. lifted its stake in shares of SPDR S&P Biotech ETF by 44.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 236,057 shares of the exchange traded fund’s stock valued at $28,782,000 after buying an additional 72,636 shares in the last quarter. Finally, World Investment Advisors acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $242,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $140.72 on Monday. The firm has a 50-day moving average of $133.56 and a 200-day moving average of $127.76. The company has a market cap of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $143.46.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.